Teewinot Life
Sciences Corporation, a Global Leader in Pharmaceutical #Cannabinoid
Production, Secures $12.3 Million Series B Round
Furthers Mission to Address Unmet
Medical Needs Across the Globe
NEW YORK and TAMPA, Fla. - May 2,
2017 (Investorideas.com Newswire) Teewinot Life Sciences Corporation
(Teewinot), an industry leader in discovery, development and commercialization
of cannabinoid-based therapeutics and the global leader in the biocatalytic
production of cannabinoids, announced today that it has closed it's $12.3
million Series B round led by Tuatara Capital, a New York based private equity
fund focused on investments in cannabis-related companies. With the original
Series B target having been set at $10 million, the funds raised were nearly 25
percent oversubscribed. Tuatara Capital also led Teewinot's $7 million Series A
round in December 2015.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/05022Teewinot.asp
Marijuana
/ Hemp Stocks
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment